Calton & Associates Inc. cut its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 31.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,430 shares of the company’s stock after selling 1,106 shares during the period. Calton & Associates Inc.’s holdings in Procter & Gamble were worth $407,000 as of its most recent SEC filing.
A number of other large investors have also recently added to or reduced their stakes in the business. RPg Family Wealth Advisory LLC purchased a new stake in shares of Procter & Gamble in the third quarter valued at $33,000. Costello Asset Management INC lifted its holdings in Procter & Gamble by 2,142.9% in the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company’s stock valued at $54,000 after purchasing an additional 300 shares in the last quarter. Mendota Financial Group LLC boosted its stake in shares of Procter & Gamble by 58.0% during the 4th quarter. Mendota Financial Group LLC now owns 376 shares of the company’s stock worth $63,000 after purchasing an additional 138 shares during the last quarter. Itau Unibanco Holding S.A. grew its holdings in shares of Procter & Gamble by 138.7% during the third quarter. Itau Unibanco Holding S.A. now owns 401 shares of the company’s stock worth $69,000 after buying an additional 233 shares in the last quarter. Finally, Hara Capital LLC acquired a new position in shares of Procter & Gamble in the third quarter valued at approximately $70,000. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Stock Performance
Shares of PG stock opened at $165.98 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The company’s fifty day moving average price is $168.54 and its two-hundred day moving average price is $169.38. The firm has a market capitalization of $389.20 billion, a P/E ratio of 26.43, a P/E/G ratio of 3.73 and a beta of 0.45. The Procter & Gamble Company has a 12 month low of $153.52 and a 12 month high of $180.43.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be issued a $1.0065 dividend. The ex-dividend date is Friday, January 24th. This represents a $4.03 annualized dividend and a yield of 2.43%. Procter & Gamble’s dividend payout ratio is presently 64.17%.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the transaction, the insider now owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This trade represents a 52.47 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 151,097 shares of company stock worth $25,635,076 in the last ninety days. 0.18% of the stock is owned by insiders.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on PG shares. Wells Fargo & Company raised their target price on shares of Procter & Gamble from $176.00 to $180.00 and gave the stock an “overweight” rating in a research report on Thursday, January 23rd. UBS Group dropped their target price on Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. JPMorgan Chase & Co. decreased their target price on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. Barclays upped their price target on shares of Procter & Gamble from $155.00 to $159.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 23rd. Finally, Evercore ISI boosted their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Eight analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $180.53.
Check Out Our Latest Stock Report on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- What is the FTSE 100 index?
- Nebius Group: Market Overreaction or Real AI Disruption?
- Where Do I Find 52-Week Highs and Lows?
- The Best Way to Invest in Gold Is…
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Why Nike Stock Could Be 2025’s Top Comeback Play
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.